Current advances in biomarkers for targeted therapy in triple-negative breast cancer
Abstract: Triple-negative breast cancer (TNBC) is a complex heterogeneous disease characterized by the absence of three hallmark receptors: human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor. Compared to other breast cancer subtypes, TNBC is more aggressive, has a...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Revisão |
| Jezik: | angleščina |
| Izdano: |
2016
|
| Online dostop: | https://doi.org/10.2147/bctt.s114659 https://www.dovepress.com/getfile.php?fileID=32807 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|